These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6191671)

  • 1. [Japanese-French cooperation in tumor pharmacotherapy: 1970-1990].
    Mathé G
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1050-70. PubMed ID: 6191671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
    Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Ribaud P; Schwarzenberg L
    Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aclacinomycin A: clinical development of a novel anthracycline antibiotic in the haematological cancers.
    Warrell RP
    Drugs Exp Clin Res; 1986; 12(1-3):275-82. PubMed ID: 3525076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron microscopic studies of the heart and light microscopic studies of the skin after treatment of golden hamsters with adriamycin, detorubicin, AD-32, and aclacinomycin.
    Dantchev D; Slioussartchouk V; Paintrand M; Hayat M; Bourut C; Mathé G
    Cancer Treat Rep; 1979 May; 63(5):875-88. PubMed ID: 455329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative microscopic study of cardiotoxicity and skin toxicity of anthracycline analogs.
    Dantchev D; Balercia G; Bourut C; Anjo A; Maral R; Mathé G
    Biomed Pharmacother; 1984; 38(7):322-8. PubMed ID: 6240996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pilot studies with aclacinomycin in patients with breast cancer or gastrointestinal tumors].
    Rainer H; Gössinger H; Lenzhofer R; Moser K; Schneeweiss B
    Wien Med Wochenschr; 1983; 133(7):183-7. PubMed ID: 6868630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I-II study of aclacinomycin for a treatment of acute myeloid leukemia.
    Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Dorval T; Ribaud P
    Biomed Pharmacother; 1984; 38(7):328-31. PubMed ID: 6596962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
    Kumai K; Kubota T; Ishibiki K; Abe O
    Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pirarubicin (THP-adriamycin)].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1988 Sep; 15(9):2819-27. PubMed ID: 3046496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-tumor effects of adriamycin, 4'-Epi-adriamycin, THP-adriamycin and mitoxantrone on rat mammary cancer induced by 7,12-dimethyl benz (A) anthracene].
    Tominaga T; Kitamura M; Yoshida Y; Kosaki G
    Gan To Kagaku Ryoho; 1984 Aug; 11(8):1663-8. PubMed ID: 6433800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aclacinomycin-A in acute leukaemias and leukaemic non-Hodgkin lymphomas (author's transl)].
    Mathé G; de Jager R; Hulhoven R; Delgado M; Machover D; Ribaud P; de Vassal F; Gil-Delgado M; Misset JL; Gouveia J; Jasmin C; Hayat M; Gastiaburu J; Schwarzenberg L
    Nouv Presse Med; 1982 Jan; 11(1):25-8. PubMed ID: 6949137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
    Warrell RP; Arlin ZA; Kempin SJ; Young CW
    Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 14. Anthracyclines, mitoxantrone, radiotherapy, and granulocyte colony-stimulating factor: risk factors for leukemia and myelodysplastic syndrome after breast cancer.
    Le Deley MC; Suzan F; Cutuli B; Delaloge S; Shamsaldin A; Linassier C; Clisant S; de Vathaire F; Fenaux P; Hill C
    J Clin Oncol; 2007 Jan; 25(3):292-300. PubMed ID: 17159192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiotoxicity of daunorubicin and aclacinomycin A in patients with acute leukemia].
    Haruyama H; Shimazaki C; Nakanishi S; Hamami T; Nisio A; Isemura T; Katsume H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):516-21. PubMed ID: 6964037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies of aclacinomycin A (ACM).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):233-7. PubMed ID: 3311189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I trial of aclacinomycin A.
    Van Echo DA; Whitacre MY; Aisner J; Applefeld MM; Wiernik PH
    Cancer Treat Rep; 1982 May; 66(5):1127-32. PubMed ID: 6952961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental studies on aclacinomycin.
    Tone H; Nishida H; Takeuchi T; Umezawa H
    Drugs Exp Clin Res; 1985; 11(1):9-15. PubMed ID: 2424701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New anthracyclines].
    Ogawa M; Ariyoshi Y
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):27-33. PubMed ID: 8422185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Phase II study of a new anthraquinone antineoplastic agent, mitoxantrone, in hematological malignancies].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1538-9. PubMed ID: 6347083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.